Clinical Trial Update: Study Evaluating MST-997 in Advanced Malignant Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating MST-997 in advanced malignant solid tumors has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasms

Drugs mentioned

• MST-997

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Neoplasms | Phase 1 | Status: TERMINATED